List of Therapeutic Companies in Arizona - 20

Anuncia Medical is a neurotherapeutic device company currently solving the large unmet need in cerebrospinal fluid (CSF) management and neurocritical care.

Applied Biologics is a fully-integrated life sciences company providing research, product development, manufacturing and distribution of medical technologies. Since 2010, Applied Biologics has been dedicated to providing innovative biologic solutions to deliver optimal patient outcomes. The entire Applied Biologics team is dedicated to each other and the company's success. The executive team, medical advisory board, scientific advisory board, researchers, product development team, manufacturing technicians, distribution team, sales representatives, support team, reimbursement department and administrative staff are professionals and leaders in their fields. Together, we continue to strive for excellence and being a leader in delivering biological solutions to treat a growing list of medical indications.

Avery Therapeutics is developing first-in-class immunomodulatory therapeutics to redirect the immune system to address diseases of aging, inflammation, and fibrosis. Avery's lead program is under development for heart failure, one of the leading causes of death in the world.

Axolotl Biologix, located in Arizona is a dynamic biotech company focused on developing and producing human biologics and biological-related products to reduce inflammation and foster regeneration for many conditions that affect patients, including orthopedic, wound care, cosmetic and more. Axolotl is currently negotiating partnerships with universities and research hospitals to find ways to improve current technologies and procedures to improve patients’ quality of life.

Calviri’s mission is to provide affordable products worldwide that will end deaths from cancer. We are a fully integrated healthcare company developing a broad spectrum of vaccines and companion diagnostics that prevent and treat cancer for those either at risk or diagnosed. We focus on using frameshift neoantigens derived from errors in RNA processing to provide pioneering products against cancer. The company is a spin out of the Biodesign Institute, Arizona State University, located in Phoenix, AZ. We have the largest dog vaccine trial in the world underway at three premier veterinary universities. The five-year trial will assess the performance of a preventative cancer vaccine. For more information, please visit www.calviri.com.

Ceria Therapeutics develops innovative drug products for inflammatory disorders. We intend to transform lives by eliminating the consequences of inflammation.

Creative Medical Technology Holdings, Inc., formerly Jolley Marketing, Inc., is a clinical-stage company. The Company conducts its business operations primarily through its subsidiary, Creative Medical Technologies, Inc. (CMT). The Company is engaged in stem cell research and applications for use to treat male and female sexual dysfunction, infertility, miscarriages and related issues. CMT focuses on completing the testing of its erectile dysfunction (ED) treatment and, if warranted, marketing treatment kits under the name Caverstem to physicians for use with their patients suffering from ED. CMT also intends to test and, if warranted, market licensed stem cell products under its infertility technology license. Procedures for use of the Company's ED stem cell treatment consist of a one-hour out-patient visit in a physician's office. The physician would harvest a patient's bone marrow from the hip using local anesthetic and separate the stem cells using a cell separator.

GT Medical Technologies, Inc. (GT), an Arizona-based medical device company, is focused on improving the lives of patients with brain tumors. GT has developed an innovative approach to treatment by combining a conformable collagen matrix with brachytherapy (radiation) seeds. The product has the promise to revolutionize treatment for 176,000 patients/year in the US alone. To date, we have treated 1000+ patients with brain tumors.

Heliae® Agriculture, a division of Heliae Development LLC, provides innovative microalgal products to the agricultural community. Dedicated experts in the soil and crop science fields, Heliae® Agriculture is focused on delivering regenerative agriculture solutions with its PhycoTerra® product portfolio. PhycoTerra® branded products are sourced from nature and work to improve overall soil microbial health, structure, water productivity, and nutrient use efficiency, which helps to increase crop yields sustainably for the planet, farmers, and consumers. Learn more about how PhycoTerra® pasteurized microalgal products will help achieve your regenerative agriculture objectives at www.phycoterra.com.

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company’s marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.

Nectero Medical is a clinical-stage biotech company pioneering novel therapies with a potential to treat aneurysmal disease and improve patients' lives.

NuvOx Pharma is a biotechnology company based in Tucson, Arizona that is developing a first-in-class oxygen therapeutic to treat life-threatening diseases where hypoxia plays a role. Over 30 animal studies have shown therapeutic effect in seven different indications. Phase Ib/II clinical trials in stroke and oncology demonstrated safety and evidence of efficacy, and the company is preparing to run a Phase IIa trial in COVID-19 patients with Acute Hypoxemic Respiratory Failure (AHRF).

Leverage nVector's advanced Adeno-Associated Virus platform to quick-launch your gene therapy strategy or accelerate existing initiatives. We enhance testing and trials with superior diagnostic biomarkers.

Quantum BioPharma is at the forefront of biotechnology, committed to advancing scientific innovation and transforming lives. Our groundbreaking research is dedicated to the development of life-saving treatments for neurodegenerative diseases, with a focus on Multiple Sclerosis (MS). Through our unwavering commitment to excellence, we are pioneering the development of Lucid-MS, a potential therapeutic aimed at remyelinating neurons in the brain and spinal cord. Our vision is to restore abilities and improve the quality of life for those affected by MS. As we advance our compounds through rigorous preclinical and clinical phases, we remain steadfast in our mission to turn scientific breakthroughs into reality. Join us in our pursuit of a brighter, healthier future, where innovation meets hope, and science saves lives.

PriZm Therapeutics is a late-stage clinical biotech company developing therapies for ultra-rare pediatric orphan diseases.

RaeSedo, Inc. is a life sciences company that focuses on identifying gaps in asthma therapeutics and uses genomics, human cells, and data to develop innovative solutions. The company has a history of collaborations in the fields of consulting, operational and financial business support, and multidisciplinary assessment and management of severe asthma.

Regenesis Biomedical is a medical device firm that develops and commercializes non-drug pain relief equipments for the treatment of chronic diseases.

Reglagene is a therapeutics company that leverages its expertise in the design and development of brain penetrant medicines to create breakthrough therapies.

Snyder Biomedical Corporation was incorporated in 2008 by Robert W. Snyder, MD, PhD, an ophthalmologist and cell biologist, and John A. Martens.

Sonoran Biosciences is a preclinical-stage pharmaceutical company that develops antibacterial gel for the treatment of surgical site infection.